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Vagus Nerve Stimulation Therapy in Pediatric
Epilepsy: Current Understanding and Future
DirectionsThe first use of vagus nerve stimulation (VNS) in humans
started in 1988.1 Over the past 20 years, many publications
have established its therapeutic role in patients with
difficult-to-treat epilepsy.1 Accordingly, VNS was approved
as a treatment for medically refractory epilepsy in Europe
in 1994, and in the United States and Canada in 1997 for
patients aged 12 years and older. The evidence supporting
VNS use for epilepsy was classified as Class I in 1999 by the
Therapeutics and Technology Assessment Subcommittee of
the American Academy of Neurology.2
Initially, VNS therapy was applied in adults. However,
many studies have also shown its effectiveness in adoles-
cent and young children. A multicenter, retrospective study
of VNS in 125 pediatric patients aged 3 to 18 years with
refractory epilepsy showed the overall seizure reduction
after 3 and 6 months was 36% and 45%, respectively.3
Common adverse events included voice change and
coughing during stimulation. Rare adverse events were
drooling and increasing hyperactivity. Another study
comparing the results of children younger than and older
than 12 years disclosed no difference in the seizure
reduction in these two groups, despite of longer history of
refractory epilepsy in the latter.4 Even in younger children,
one study for six children less than 3 years of age showed
>60% seizure reduction in four of them.5 The study of VNS
therapy on cognition, quality of life, behavior, and mood in
15 children with therapy resistant epilepsy demonstrated
significant impact of improvement of quality of life,
behavior, and mood after use of VNS.6
The antiepileptic effects for VNS are multifactorial,
though the exact mechanism remains unclear.1 From the
current understanding, effective VNS therapy probably
involves the following processes: (a) an increase of synaptic
activity in the thalamus and thalamocortical projection,
which might result in a decreased synchrony of synaptic
activities between cortical neurons, (b) decreased synaptic
activity in the limbic system, (c) intermittent increase of
synaptic activities in central autonomic system, and (d)1875-9572/$36 Copyright ª 2012, Taiwan Pediatric Association. Publish
doi:10.1016/j.pedneo.2012.05.003increased release of norepinephrine and serotonin over
cortical regions, which are mostly innervated, directly or
indirectly, by the spread of vagus nerve fibers.
In this issue of Pediatrics and Neonatology, Chen and
colleagues7 report the preliminary study of short-term
results of VNS in pediatric patients with refractory
epilepsy from a multicenter cooperative survey. Actually,
this report is a part product of the nationwide cooperative
study of Taiwan Child Neurology Society under a project
called the “Clinical Study on the Catastrophic Pediatric
Refractory Epilepsy Patients with Vagus Nerve Stimulation
in Relation to Seizure Reduction, Intelligence Quotient,
Memory, Alertness, Verbal and Speech Ability” during 2009
to 2011. Another project called “Long-term Outcome of
Vagus Nerve Stimulation in Seizure Reduction, Intelligence
Quotient, Memory, Alertness, Verbal and Speech Improve-
ment on the Catastrophic Pediatric Refractory Epilepsy
Patients” is currently underway.
In this report, the authors describe the results of VNS
therapy for refractory epilepsy in a sample of four adoles-
cents and four children with a follow-up duration ranging
from 9 to 33 months. Five of the eight patients responded
to VNS, and four of them experienced a  90% seizure
reduction. No significant adverse effects were noted in all
patients during the observation period. This report suggests
that VNS is well tolerated in pediatric patients and can be
a favorable and safe therapy for children with intractable
seizures.
Some limitations exist in this study. First, the case
number is rather small. Compared to the fact that a total of
more than 60 cases so far have been collected till the end
of 2011, the preliminary data shown here might not the true
picture of VNS effect for Taiwanese children. Second, the
study participants are limited in seizure diagnosis. It does
not cover the major epilepsies and epileptic syndromes of
all difficult seizures in children. Nevertheless, this study
may highlight an optimistic therapeutic direction for those
suffering from difficult-to-treat seizures and also warranted by Elsevier Taiwan LLC. All rights reserved.
156 Editorialfurther larger scale, multicenter cooperative studies in
Taiwan.
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